The Europe Laser BPH Devices Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028).
Urine tests are done to measure the urine release of the patient. This shows the doctor if the urethra is obstructed or blocked. There are many types, like the urinalysis, which tests the patient’s urine sample to check for essential things such as blood, glucose, signs of infection, protein, and other factors that can help the urologist to identify the cause of the symptoms.
Urine tests are also utilized to screen for bladder cancer. Proper medical attention is advised If the patient has blood in their urine, burning or pain when they pass urine or are unable to pass urine. Post-void residual volume (PVR) measures urine left in the bladder after passing the urine. This is done to diagnose the issues and can be performed before the surgery. Uroflowmetry measures how fast the urine flows. The urodynamic pressure flow study, is used to test the pressure in the bladder during urination.
In England, it is estimated that 3.8 million people between the age of 16 and over have diabetes, which is equal to 8.6% of the population of this age group. The rate of diabetes is higher in men (9.6%) than in women (7.6%). There is also an association between age and diabetes which is why people with higher age are more prone to diabetes. 9% of people aged between 45 to 54 had diabetes, whereas 23.8% of people aged above 75 and over were suffering from diabetes. By 2035, the prevalence of diabetes is anticipated to increase by 9.7% or to around 4.9 million. With the increasing number pf patients with diabetes, the prevalence of BPH will also increase and thereby surge various treatment options like leaser which will boost the market growth
The Germany market dominated the Europe Laser BPH Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $41.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 3.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.4% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on Procedure, the market is segmented into Photoselective Vaporization of Prostate and Holium Laser Ablation. Based on Type, the market is segmented into Holmium Laser, Thulium Laser, Green Light Laser and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Laser BPH Devices Market will Hit $619.9 Billion by 2028, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
By End User
By Procedure
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
